Aspen Aerogels, Inc.
ASPN · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $1 | $1 |
| - Cash | $151 | $0 | $0 | $0 |
| + Debt | $80 | $0 | $0 | $0 |
| Enterprise Value | -$70 | $0 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -6.4% | -0.9% | -36% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 28.5% | 32.4% | 29% | 38.3% |
| EBITDA | $0 | $0 | -$0 | $0 |
| % Margin | 3.6% | 0.8% | -371.5% | 16.4% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -8.7% | -11.6% | -382.7% | 9.2% |
| EPS Diluted | -0.08 | -0.11 | -3.67 | 0.14 |
| % Growth | 27.3% | 97% | -2,721.4% | – |
| Operating Cash Flow | $0 | -$0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | $0 |